These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1650161)
1. Fabry disease: detection of 13-bp deletion in alpha-galactosidase A gene and its application to gene diagnosis of heterozygotes. Ishii S; Sakuraba H; Shimmoto M; Minamikawa-Tachino R; Suzuki T; Suzuki Y Ann Neurol; 1991 May; 29(5):560-4. PubMed ID: 1650161 [TBL] [Abstract][Full Text] [Related]
2. Fabry disease: detection of gene rearrangements in the human alpha-galactosidase A gene by multiplex PCR amplification. Kornreich R; Desnick RJ Hum Mutat; 1993; 2(2):108-11. PubMed ID: 8318986 [TBL] [Abstract][Full Text] [Related]
3. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes. Ashton-Prolla P; Tong B; Shabbeer J; Astrin KH; Eng CM; Desnick RJ J Investig Med; 2000 Jul; 48(4):227-35. PubMed ID: 10916280 [TBL] [Abstract][Full Text] [Related]
4. A missense mutation, A156T, in the alpha-galactosidase A gene causes typical Fabry disease. Konoshita T; Mutoh H; Yokoi T; Koni I; Miyamori I; Mabuchi H Clin Nephrol; 2001 Mar; 55(3):243-7. PubMed ID: 11316246 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Eng CM; Desnick RJ Hum Mutat; 1994; 3(2):103-11. PubMed ID: 7911050 [TBL] [Abstract][Full Text] [Related]
6. A carboxy-terminal truncation of human alpha-galactosidase A in a heterozygous female with Fabry disease and modification of the enzymatic activity by the carboxy-terminal domain. Increased, reduced, or absent enzyme activity depending on number of amino acid residues deleted. Miyamura N; Araki E; Matsuda K; Yoshimura R; Furukawa N; Tsuruzoe K; Shirotani T; Kishikawa H; Yamaguchi K; Shichiri M J Clin Invest; 1996 Oct; 98(8):1809-17. PubMed ID: 8878432 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel point mutation (S65T) in alpha-galactosidase A gene in Chinese patients with Fabry disease. Mutations in brief no. 169. Online. Chen CH; Shyu PW; Wu SJ; Sheu SS; Desnick RJ; Hsiao KJ Hum Mutat; 1998; 11(4):328-30. PubMed ID: 9554750 [TBL] [Abstract][Full Text] [Related]
8. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches. Germain DP; Poenaru L Biochem Biophys Res Commun; 1999 Apr; 257(3):708-13. PubMed ID: 10208848 [TBL] [Abstract][Full Text] [Related]
9. Point mutation in the alpha-galactosidase A gene of atypical Fabry disease with only nephropathy. Sawada K; Mizoguchi K; Hishida A; Kaneko E; Koide Y; Nishimura K; Kimura M Clin Nephrol; 1996 May; 45(5):289-94. PubMed ID: 8738659 [TBL] [Abstract][Full Text] [Related]
10. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography. Shabbeer J; Robinson M; Desnick RJ Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228 [TBL] [Abstract][Full Text] [Related]
11. [Molecular genetics of inherited metabolic diseases--its application to the investigation of pathogenesis and the diagnosis of Fabry disease]. Sakuraba H Rinsho Byori; 1994 Jun; 42(6):628-35. PubMed ID: 7914243 [TBL] [Abstract][Full Text] [Related]
12. A 3' splice site consensus sequence mutation in the intron 3 of the alpha-galactosidase A gene in a patient with Fabry disease. Yokoi T; Shinoda K; Ohno I; Kato K; Miyawaki T; Taniguchi N Jinrui Idengaku Zasshi; 1991 Sep; 36(3):245-50. PubMed ID: 1753437 [TBL] [Abstract][Full Text] [Related]
13. New point mutation (R301X) of the alpha-galactosidase A gene causing Fabry disease. Kawanishi C; Osaka H; Inoue K; Onishi H; Yamada Y; Sugiyama N; Suzuki K; Hanihara T; Miyagawa T; Kimura S Hum Mutat; 1995; 6(2):186-7. PubMed ID: 7581405 [No Abstract] [Full Text] [Related]
14. Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype. Ashley GA; Shabbeer J; Yasuda M; Eng CM; Desnick RJ J Hum Genet; 2001; 46(4):192-6. PubMed ID: 11322659 [TBL] [Abstract][Full Text] [Related]
15. The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease. Kornreich R; Bishop DF; Desnick RJ Trans Assoc Am Physicians; 1989; 102():30-43. PubMed ID: 2561643 [No Abstract] [Full Text] [Related]
16. Fabry disease: molecular carrier detection and prenatal diagnosis by analysis of closely linked polymorphisms at Xq22.1. Caggana M; Ashley GA; Desnick RJ; Eng CM Am J Med Genet; 1997 Aug; 71(3):329-35. PubMed ID: 9268104 [TBL] [Abstract][Full Text] [Related]
17. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease. Duro G; Musumeci MB; Colomba P; Zizzo C; Albeggiani G; Mastromarino V; Volpe M; Autore C Gene; 2014 Feb; 535(2):365-9. PubMed ID: 24140492 [TBL] [Abstract][Full Text] [Related]
18. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease. Mirceva V; Hein R; Ring J; Möhrenschlager M Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840 [TBL] [Abstract][Full Text] [Related]
19. Molecular analysis in Fabry disease in Spain: fifteen novel GLA mutations and identification of a homozygous female. Rodríguez-Marí A; Coll MJ; Chabás A Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938095 [TBL] [Abstract][Full Text] [Related]
20. Heterozygote detection in Fabry disease utilizing multiple enzyme activities. Sheth KJ; Good TA; Murphy JV Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]